Literature DB >> 4724188

Reduction by 9-tetrahydrocannabinol in the blood pressure of hypertensive rats bearing regenerated adrenal glands.

M K Birmingham.   

Abstract

A suspension of (-)-Delta(9)-trans-tetrahydrocannabinol (Delta(9)-THC) (3 mg/kg body wt) was administered daily for one week by i.p. injection to female rats showing the syndrome of adrenal regeneration hypertension (ARH). Other ARH rats received no injections or injections of vehicle only. On the first day, Delta(9)-THC decreased the average blood pressure by 38+/-6 mmHg 1 h, 31+/-5 mmHg 3 h, and 11+/-5 mmHg 5 h after injection (n=0). On subsequent days the acute effect disappeared, but statistically highly significant decreases were observed between the blood pressures of the Delta(9)-THC-treated group and those of the other two groups. Plasma corticosterone concentrations, measured on the eighth day of treatment, one hour after injection time, averaged 26.+/-2.7 mug/100 ml in the untreated animals, 26.6+/-2.0 mug/100 ml in the vehicle-injected animnals, and 21.3+/-2.4 mug/100 ml in the animals injected with Delta(9)-THC. The findings indicate that Delta(9)-THC, at a moderate dose for the rat, is capable of lowering the blood pressure in rats suffering from adrenal regeneration hypertension and that chronic administration of Delta(9)-THC does not appear to stimulate the pituitary-adrenal axis, in contrast to reported effects of acute administration (Barry, Perhach & Kubena, 1970).

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4724188      PMCID: PMC1776093          DOI: 10.1111/j.1476-5381.1973.tb08236.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  9 in total

1.  Some pharmacological effects of two tetrahydrocannabinols.

Authors:  R DAGIRMANJIAN; E S BOYD
Journal:  J Pharmacol Exp Ther       Date:  1962-01       Impact factor: 4.030

2.  Development of hypertension and cardiovascular-renal lesions during adrenal regeneration in the rat.

Authors:  F R SKELTON
Journal:  Proc Soc Exp Biol Med       Date:  1955-11

3.  The estimation of small amounts of corticosterone in rat plasma.

Authors:  N ZENKER; D E BERNSTEIN
Journal:  J Biol Chem       Date:  1958-04       Impact factor: 5.157

Review 4.  Marihuana in man: three years later.

Authors:  L E Hollister
Journal:  Science       Date:  1971-04-02       Impact factor: 47.728

Review 5.  On the pharmacology of marihuana.

Authors:  S Gershon
Journal:  Behav Neuropsychiatry       Date:  1970-01

6.  Effects of (--)delta-9-trans-tetrahydrocannabinol in man.

Authors:  H Isbell; C W Gorodetzsky; D Jasinski; U Claussen; F von Spulak; F Korte
Journal:  Psychopharmacologia       Date:  1967

7.  Marijuana: some pharmacological studies.

Authors:  B T Ho; R An; G E Fritchie; L F Englert; W M McIsaac; B Mackay; D N Ho
Journal:  J Pharm Sci       Date:  1971-11       Impact factor: 3.534

8.  Pharmacologic properties of some cannabis related compounds.

Authors:  J C Garriott; R B Forney; F W Hughes; A B Richards
Journal:  Arch Int Pharmacodyn Ther       Date:  1968-02

Review 9.  Chemistry and pharmacology of marijuana.

Authors:  J L Neumeyer; R A Shagoury
Journal:  J Pharm Sci       Date:  1971-10       Impact factor: 3.534

  9 in total
  9 in total

1.  Tolerance to the cardiovascular effects of delta9-tetrahydrocannabinol in the rat.

Authors:  M D Adams; L D Chait; J T Earnhardt
Journal:  Br J Pharmacol       Date:  1976-01       Impact factor: 8.739

Review 2.  The endocannabinoid system as an emerging target of pharmacotherapy.

Authors:  Pál Pacher; Sándor Bátkai; George Kunos
Journal:  Pharmacol Rev       Date:  2006-09       Impact factor: 25.468

Review 3.  Cardiovascular pharmacology of cannabinoids.

Authors:  P Pacher; S Bátkai; G Kunos
Journal:  Handb Exp Pharmacol       Date:  2005

4.  Effect of the cannabinoid receptor agonist WIN55212-2 on sympathetic cardiovascular regulation.

Authors:  N Niederhoffer; B Szabo
Journal:  Br J Pharmacol       Date:  1999-01       Impact factor: 8.739

Review 5.  Blood pressure regulation by endocannabinoids and their receptors.

Authors:  Pál Pacher; Sándor Bátkai; George Kunos
Journal:  Neuropharmacology       Date:  2005-02-19       Impact factor: 5.250

6.  BRL 13776: a novel antihypertensive agent with interesting monoamine depleting properties.

Authors:  J Melrose; M G Palfreyman; R H Poyser; R L Whiting
Journal:  Br J Pharmacol       Date:  1977-11       Impact factor: 8.739

7.  Corticotrophin and corticosterone secretion following delta 1-Tetrahydrocannabinol, in intact and in hypothalamic deafferentated male rats.

Authors:  M Puder; J Weidenfeld; I Chowers; I Nir; N Conforti; R A Siegel
Journal:  Exp Brain Res       Date:  1982       Impact factor: 1.972

8.  Endocannabinoid system in cardiovascular disorders - new pharmacotherapeutic opportunities.

Authors:  Pedro Cunha; Ana M Romão; Filipa Mascarenhas-Melo; Helena M Teixeira; Flávio Reis
Journal:  J Pharm Bioallied Sci       Date:  2011-07

Review 9.  A Systematic Review and Meta-Analysis of the In Vivo Haemodynamic Effects of Δ⁸-Tetrahydrocannabinol.

Authors:  Salahaden R Sultan; Sophie A Millar; Saoirse E O'Sullivan; Timothy J England
Journal:  Pharmaceuticals (Basel)       Date:  2018-01-31
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.